Saturday - April 18, 2026

Category Archives: Marketing & Sales

HSV-1 Keratitis Pipeline Poised for Transformational Shift by 2026, Driven by Gene-Editing Innovations and Next-Generation Antiviral Strategies | DelveInsight

HSV-1 Keratitis Pipeline HSV-1 Keratitis Key companies working in the market are AiCuris Anti-infective Cures AG, Shanghai BDgene Co., Ltd, Excision BioTherapeutics, Inc, and others. “Hsv-1-Keratitis Pipeline Insight, 2026” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs … Continue reading →

Bread Loaf’s CEO Mark Milutin Breaks Down FDA Peptide Shift and What It Means for Telehealth

“This is telehealth’s 2012 e-commerce moment. Regulation, consumer demand, and technology are aligning at the same time — and the operators who move first aren’t just going to win, they’re going to define the category.” — Mark Milutin, Founder, Bread … Continue reading →

Neurostimulation Devices Market Projected to Reach USD 22.3 Billion by 2034: DelveInsight | Medtronic, Boston Scientific, and Abbott

Neurostimulation Devices Market Insights The leading companies in the neurostimulation devices landscape include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, and LivaNova, which collectively held a market share of approximately 65-70% in 2024. These companies focus on innovation pipelines that … Continue reading →

Active Implantable Medical Devices Market Projected to Reach USD 44.9 Billion by 2032 with a 6.71% CAGR: DelveInsight | Medtronic, Abbott, and Cochlear Ltd.

Active Implantable Medical Devices Market Insights Leading companies operating in the active implantable medical devices market include Medtronic, Abbott, and Cochlear Ltd., all of which are actively pursuing technical innovations and strategic acquisitions to expand their market footprint. The global … Continue reading →

Osteoporosis Pipeline Expands as 30+ Companies Advance Innovative Bone Health Therapies, Finds DelveInsight | Alvotech, Transcenta Holding, GlycoNex

Osteoporosis – Pipeline Insight, 2026 There are 30+ key companies, including Alvotech, Transcenta Holding, GlycoNex, and others, developing therapies for Osteoporosis across multiple stages of clinical development. The competitive landscape is characterized by a focus on novel monoclonal antibodies, biosimilars, … Continue reading →

Traumatic Brain Injury Pipeline Grows as 20+ Pharma Companies Advance Novel TBI Therapies, Finds DelveInsight | Oragenics, SHINKEI Therapeutics, AlzeCure, Algernon Pharmaceutical

Traumatic Brain Injury (TBI) – Pipeline Insight, 2026 There are 20+ key companies, including Oragenics, SHINKEI Therapeutics, AlzeCure, Algernon Pharmaceutical, and others, developing therapies for Traumatic Brain Injury. The current treatment landscape relies on managing symptoms with off-label medications, meaning … Continue reading →

Lulu Blinds Expands Motorized Blinds Services in Canada Amid Rising Demand for Smart Home Automation

As smart home adoption continues to accelerate across the country, Lulu Blinds has announced the expansion of its motorized blinds services in Canada, responding to growing consumer demand for convenience, energy efficiency, and modern interior solutions. The move reinforces the … Continue reading →

Qingdao Yingruis Fitness Technology Co., Ltd. Accelerates Global B2B Procurement Demand for Commercial Gym Equipment and OEM/ODM Fitness Solutions in 2026

Qingdao Yingruis Fitness Technology Co., Ltd. Yingruis Fitness Equipment Manufacturer & Supplier (Qingdao Yingruis Fitness Technology Co., Ltd.) is a China-based fitness equipment manufacturer and supplier specializing in commercial gym equipment, including cardio, strength, Pilates, and garage gym systems. Founded … Continue reading →

Fabry Disease Market Estimated at USD 1.7 Billion in 2024, Reports DelveInsight

Fabry Disease Market Leading organizations engaged in the Fabry disease domain include Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, GREENOVATION BIOTECH GMBH, Shire, Takeda, Amicus Therapeutics, Protalix, uniQure, Codexis, MP6 Therapeutics, CellGenTech, and several … Continue reading →